Table 1.
Parameter |
PFS |
OS |
||
Median (mo) | Log-rank P | Median (mo) | Log-rank P | |
All eligible patients (n = 824) | 2.9 | 5.6 | ||
Gem (n = 275) | 2.6 | 4.9 | ||
FDR Gem (n = 277) | 3.5 | 0.09 | 6.2 | 0.15 |
GemOx (n = 272) | 2.7 | 5.7 |
PFS: Progression-free survival; OS: Overall survival; ECOG: Eastern Cooperative Oncology Group; Gem: Gemcitabine; GemOx: Gem and oxaliplatin.